trapped gas glp 1 Potential Use of GLP-1 and GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at? Primer: The Skinny on GLP-1s

Understanding personal risk factors and medication characteristics can support safer treatment

The airball comes as Novo scrambles to regain a majority share of the GLP-1 market.

With the news that consumer food spending is in decline, attributed to the growing popularity of Ozempic and other similar medications, we dive into the impact of GLP-1 on the food industry

Although use of glucagon-like peptide-1 agonists for diabetes and weight loss has soared with indications now expanding into liver diseases, specifically metabolic dysfunction-associated steatohepatitis, the jury is still out on its benefit.With the recent FDA approval of Rezdiffra (resmetirom, Madrigal Pharmaceuticals) for the treatment for MASH, the question is whether (and how) GLP-1s will fit

Learn the essentials of an FDA Import Alert, including types, reasons for detentions, and how to navigate compliance, shipment release, & FDA red list removal.

What looks like a weight-loss drug is actually becoming a platform - pulling consumers into diagnostics, coaching, aesthetics, supplements, and long-term transformation journeys